Entity Common Stock, Shares Outstanding of RVL Pharmaceuticals plc from 07 Nov 2018 to 11 Aug 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
RVL Pharmaceuticals plc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 07 Nov 2018 to 11 Aug 2023.
  • RVL Pharmaceuticals plc Entity Common Stock, Shares Outstanding for the quarter ending 11 Aug 2023 was 99,535,197, a 0.39% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

RVL Pharmaceuticals plc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 99,535,197 +385,242 +0.39% 11 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 99,349,814 +15,834,403 +19% 17 Mar 2023 10-K 20 Mar 2023 2022 FY
Q3 2022 99,153,744 +15,873,153 +19% 09 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 99,149,955 +36,264,782 +58% 10 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 83,515,411 +20,796,280 +33% 29 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 83,280,591 +20,694,759 +33% 12 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 62,885,173 -898,127 -1.4% 13 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 62,719,131 +3,820,423 +6.5% 29 Mar 2021 10-K 30 Mar 2021 2020 FY
Q3 2020 62,585,832 +10,659,709 +21% 09 Nov 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 63,783,300 +11,264,376 +21% 10 Aug 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 58,898,708 +6,379,784 +12% 10 Mar 2020 10-K 19 Mar 2020 2019 FY
Q3 2019 51,926,123 -592,801 -1.1% 13 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 52,518,924 07 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 52,518,924 27 Mar 2019 10-K 28 Mar 2019 2018 FY
Q3 2018 52,518,924 07 Nov 2018 10-Q 08 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.